1415248-46-2

Upstream product

• 1414943-88-6 (rac)-4-(4-fluoro-2-methoxyphenyl)-N-{3-[(S-methylsulfonimidoyl)methyl]phenyl}-1,3,5-triazin-2-amine 
• 624-83-9 methyl isocyanate 
• 51392-54-2 1-[(methylsulfanyl)methyl]-3-nitrobenzene 
• 619-23-8 3-Nitrobenzyl chloride 
• 1414944-11-8 (rac)-1-[(methylsulfinyl)methyl]-3-nitrobenzene 
• 1414944-18-5 (rac)-1-[(S-methylsulfonimidoyl)methyl]-3-nitrobenzene 
• 1414943-84-2 (rac)-ethyl [(3-{[4-(4-fluoro-2-methoxyphenyl)-1,3,5-triazin-2-yl]amino}benzyl)(methyl)oxido-λ⁶-sulfanylidene]carbamate 
• 1414944-15-2 (rac)-2,2,2-trifluoro-N-[methyl(3-nitrobenzyl)oxido-λ⁶-sulfanylidene]acetamide 
• 1414944-20-9 (rac)-ethyl [methyl(3-nitrobenzyl)oxido-λ⁶-sulfanylidene]carbamate 
• 1414944-22-1 (rac)-ethyl [(3-aminobenzyl)(methyl)oxido-λ⁶-sulfanylidene]carbamate 
• 1414944-24-3 (rac)-ethyl [{3-[(4-chloro-1,3,5-triazin-2-yl)amino]benzyl}(methyl)-oxido-λ⁶-sulfanylidene]carbamate 
• 1415250-23-5 4-(4-fluoro-2-methoxyphenyl)-N-{3-[(S-methylsulfinyl)methyl]phenyl}-1,3,5-triazin-2-amine 

Relevant academic research and scientific papers

4-ARYL-N-PHENYL-1,3,5-TRIAZIN-2-AMINES CONTAINING A SULFOXIMINE GROUP

The present invention relates to 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group of general formula (I) or (Ia) as described and defined herein, and methods for their preparation, their use for the treatment and/or prophylaxis of disorders, in particular of hyper-proliferative disorders and/or virally induced infectious diseases and/or of cardiovascular diseases. The invention further relates to intermediate compounds useful in the preparation of said compounds of general formula (I) or (Ia).